Chordate Medical (Sweden) Today
| CMH Stock | 12.55 0.25 1.95% |
Performance0 of 100
| Odds Of DistressOver 68
|
Chordate Medical is selling for under 12.55 as of the 22nd of December 2024; that is 1.95 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 12.55. Chordate Medical has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of December 2024. Click here to learn more.
Moving together with Chordate Stock
| 0.61 | XVIVO | Xvivo Perfusion AB | PairCorr |
| 0.78 | BICO | BICO Group AB | PairCorr |
| 0.79 | ADDV-B | ADDvise Group B | PairCorr |
| 0.66 | MNTC | Mentice AB | PairCorr |
Moving against Chordate Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Chordate Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Chordate Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Chordate Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Drugs, Medical Devices, Healthcare (View all Sectors) |
Chordate Medical Holding (CMH) is traded on Stockholm Exchange in Sweden and employs 3 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 80.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chordate Medical's market, we take the total number of its shares issued and multiply it by Chordate Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Chordate Medical Holding operates under Healthcare sector and is part of Medical Devices industry. The entity has 157.71 M outstanding shares.
Chordate Medical generates negative cash flow from operations
Check Chordate Medical Probability Of Bankruptcy
Ownership AllocationChordate Medical holds a total of 157.71 Million outstanding shares. Chordate Medical Holding retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Chordate Ownership Details
Chordate Medical Holding Risk Profiles
Although Chordate Medical's alpha and beta are two of the key measurements used to evaluate Chordate Medical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.2 | |||
| Standard Deviation | 5.91 | |||
| Variance | 34.95 | |||
| Risk Adjusted Performance | (0.10) |
Chordate Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Chordate Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Chordate Medical Corporate Management
Elected by the shareholders, the Chordate Medical's board of directors comprises two types of representatives: Chordate Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chordate. The board's role is to monitor Chordate Medical's management team and ensure that shareholders' interests are well served. Chordate Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chordate Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jan Hermansson | Head Director | Profile | |
| Anders Weilandt | CEO MD | Profile | |
| Jan Lindberg | CTO Mang | Profile | |
| Niklas Lindecrantz | Chief Officer | Profile | |
| Helena Thedius | Sales Mang | Profile |
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.